Skip to main content
Read more
Nina Willer, who used hybrid closed loop technology through pregnancy, and her child.
Policy and advocacy Treatment research Treatments Type 1 technology
7 November 2023

Hybrid closed loop technology set to be made available in England and Wales

The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.

Read more
T cell immune system
Research Treatment research Treatments
6 November 2023

New research highlights the effectiveness of immune therapies for type 1 diabetes

The research, which was co-funded by JDRF, reveals that drugs that target the immune system offer very effective and rapid improvements in stabilising blood sugar levels, often within just three months.

Read more
Dr Ify Mordi, lead type 1 diabetes researcher
Complications Treatment research
25 October 2023

JDRF award £1.5 million grant to University of Dundee for type 1 diabetes clinical trial

The new JDRF-funded clinical trial called SOPHIST will test a drug to help people with type 1 diabetes and heart failure.

Read more
Young person receiving an injection of the immunotherapy drug teplizumab.jpg
Clinical trials Prevention research Research
18 October 2023

Clinical trial finds teplizumab slows type 1 diabetes in people newly diagnosed 

Results from a clinical trial called the PROTECT study show that teplizumab can preserve beta cell function in children and adolescents newly diagnosed with type 1 diabetes.

Read more
ELSA testing kits to screen for type 1 diabetes in children
Clinical trials Prevention research Research
16 October 2023

Trial to screen children for type 1 diabetes now available in Northern Ireland

Children in Northern Ireland are now eligible for a trial screening programme that will identify those at high risk of developing type 1 diabetes in the future.

Read more
A hand holding a plastic model of a kidney
Clinical trials Complications Research Treatment research
13 October 2023

JDRF commits £1.3 million to investigate medication with the potential to delay kidney complications

Thanks to JDRF supporters, we’ve been able to award a £1.3 million grant to King’s College London (KCL) and Steno Diabetes Center Copenhagen to examine how existing drugs, known as SGLT inhibitors, could delay the progression of kidney disease in people living with type 1 diabetes.

Read more
A woman with type 1 diabetes who is discussing pregnancy with a nurse
5 October 2023

New trial shows benefits of hybrid closed loop in pregnancy  

A JDRF-supported trial published in the New England Journal of Medicine and presented at the European Association for the Study of Diabetes conference has shown that hybrid closed loop technology helps pregnant women better manage their blood sugars compared to traditional insulin pumps or multiple daily injections.  

Read more
A graph from the research paper showing that the people with type 1 diabetes who took the antiviral drugs had higher levels of C-peptide (insulin production) than those on the placebo.
Clinical trials
5 October 2023

Antiviral drugs could maintain beta cell function in children newly diagnosed with type 1 diabetes

A clinical trial funded by JDRF suggests that treating children with antiviral drugs when they are first diagnosed with type 1 diabetes could preserve their ability to produce some insulin.

Read more
Aaron Kowalski (JDRF International CEO), Karen Addington (JDRF UK CEO) and Professor Roman Hovorka
4 October 2023

Professor Roman Hovorka wins prestigious award at Europe’s largest diabetes conference

Professor Roman Hovorka, who JDRF has funded since 2006 to develop hybrid closed loop (HCL) technology, has won this year’s EASD-Novo Nordisk Foundation Diabetes Prize for Excellence.

Read more
A young guy with type 1 diabetes dealing with exam stress and taking an exam
Policy and advocacy
4 October 2023

Letter to Gillian Keegan about the use of mobile phones in schools

We’ve written a letter to Gillian Keegan MP, Secretary of State for Education, asking her to make exemptions to the Government’s policy on banning mobile phones in schools. We thought you might like to read it.

Read more
Close up of someone kneeling down and tying the shoelace on their trainer whilst on a running track
Living with type 1 Research
27 September 2023

People with type 1 diabetes held back from sport due to stigma and fear of hypos

Our survey has shown that half of people with type 1 diabetes feel that the condition holds them back from physical activity and exercise.

Read more
Illustration of the hybrid closed loop technology system, funded as part of treatment research for type 1 diabetes by JDRF.
Policy and advocacy Type 1 technology
21 August 2023

NICE’s latest consultation on hybrid closed loop

As part of its assessment of hybrid closed loop (HCL), the National Institute for Health and Care Excellence (NICE) has today published an additional consultation on its roll out.

Read more
Researcher Safiya Naina Marikar pipetting in the lab.
Cure research Treatment research
12 July 2023

JDRF-funded researchers make pancreatic ductal cells sense and release insulin

In a JDRF-funded research project in Australia, scientists have turned human pancreatic ductal cells into insulin-producing cells, offering promise for restoring the ability to make insulin in people living with type 1 diabetes.

Read more
Her Majesty the Queen talking to women researchers at a research laboratory
29 June 2023

Her Majesty The Queen tours laboratory aiming to stop type 1 diabetes in its tracks

We have today welcomed our President, Her Majesty The Queen, to University College London (UCL) Institute of Immunity and Transplantation.

Read more
A woman standing in a park using the Omnipod 5 system for type 1 diabetes
Type 1 technology
21 June 2023

Omnipod 5 becomes the latest hybrid closed loop system available in the UK

Insulet, the company who make Omnipod® products, has announced that their Omnipod® 5 hybrid closed loop (HCL) technology is now available in the UK.

Read more
DNA double helix and sequencing
Prevention research
19 June 2023

Children develop type 1 diabetes differently due to the activation of different genes

In a study co-funded by JDRF and Diabetes UK, researchers identified 13 genes involved in immune responses, which are activated specifically in people who develop type 1 diabetes at a young age.

Read more
Nadia Swann, Wilson Leech and Sarah Johnson
1 June 2023

JDRF announces new Board appointments

We’re pleased to announce the appointment of two new Board Directors, Nadia Swann and Sarah Johnson.

Read more
A hybrid closed loop technology sensor
Type 1 technology
27 April 2023

Abbott, Ypsomed and CamDiab team up to offer hybrid closed loop with more affordable sensor technology

Abbott has announced that its FreeStyle Libre® 3 sensor is now authorised to work with Ypsomed’s mylife™ YpsoPump and CamDiab’s CamAPS FX mobile app.

Read more
Islet cells from human donors
Research Treatment research Treatments
20 April 2023

Transplanted beta cells avoid immune attack in mice with type 1 diabetes

Genetically engineered beta cells transplanted into mice with type 1 diabetes avoid immune system attack and stabilise blood glucose levels without immunosuppressants.

Read more
African Caribbean people with type 1 diabetes are more at risk of sight loss and diabetic retinopathy
Complications Research
18 April 2023

African Caribbean people with type 1 diabetes are more at risk of sight loss

New research from Kings College London found that African Caribbean people with type 1 diabetes are more likely to develop diabetic retinopathy, which can lead to sight loss.

Read more
Dr Victoria Salem
Cure research Partnerships Research
27 March 2023

Type 1 Diabetes Grand Challenge invests £5 million to kick off the race towards a cure

We’re excited to reveal the first research projects funded by the Type 1 Diabetes Grand Challenge, our partnership with the Steve Morgan Foundation and Diabetes UK.

Read more
Type 1 diabetes researchers awarded JDRF UK Small Grant Awards
15 March 2023

JDRF funds small pilot projects exploring promising diabetes research ideas

We are delighted to announce the recipients of our latest Small Grant Awards: Dr Joanna Boldison, Dr Fiona Docherty and Dr Nicholas Thomas.

Read more
Daphne Jackson Fellowship logo
Partnerships Research
13 March 2023

JDRF sponsors Daphne Jackson Fellowship

We are delighted to announce our latest partnership funding opportunity, offered through the Daphne Jackson Trust.

Read more
A woman takes the drug verapamil, used to slow progression of type 1 diabetes
Clinical trials Research Treatment research Treatments
8 March 2023

JDRF-funded clinical trial drug slows type 1 diabetes in young people

An existing drug, called verapamil slowed the progression of type 1 diabetes in newly diagnosed children and adolescents in a clinical trial funded by JDRF.

Read more
Diabetic kidney disease predictive genetic test researchers
Complications Prevention research Research
16 February 2023

JDRF-funded researchers develop a genetic test to detect diabetic kidney disease early

Researchers have identified genes that predict the development and progression of diabetic kidney disease, giving us the potential to limit how many people with type 1 experience kidney failure.

Read more
Myaware logo - Fighting Myasthenia Together
Partnerships Research
18 January 2023

Partnership funding autoimmune research now has over 10 members

Myaware, the only charity in the UK focusing on people affected by myasthenia, is the latest organisation to join Connect Immune Research.

Read more
Illustration of the hybrid closed loop technology system, funded as part of treatment research for type 1 diabetes by JDRF.
Type 1 technology
13 January 2023

Hybrid closed loop to be recommended for over 100,000 people with type 1 diabetes

Draft guidance has been published which recommends that the NHS fund hybrid closed loop (HCL) systems, following years of dedicated research and campaigning by JDRF.

Read more
JDRF's 2022 in review
21 December 2022

Our 2022 Year in Review

A lot has happened over the last 12 months at JDRF, and in the world of type 1 diabetes as a whole. From research breakthroughs to herculean fundraising efforts, here’s a retrospective of everything we’ve been celebrating in 2022.

Read more
Dan Doherty in the lab
9 December 2022

JDRF and Medical Research Council co-fund new research into type 1 diabetes treatments

Daniel Doherty has received the UK Medical Research Council (MRC) Clinical Research Training Fellowship, which will be co-funded by JDRF for the first time.

Read more
28 November 2022

Connect Immune Research partnership welcomes the Royal Free Charity

The Royal Free Charity, which supports the three hospitals in the Royal Free London NHS Foundation Trust, is the newest member of the Connect Immune Research initiative.

Read more
Sally and Steve Morgan in JDRF-funded lab
Funding Partnerships Research
22 November 2022

Team of international scientific experts to advise on £50 million investment into type 1 diabetes research

The Type 1 Diabetes Grand Challenge – a partnership between the Steve Morgan Foundation, Diabetes UK and JDRF UK– has successfully appointed 17 leading international scientists.

Read more
A girl with type 1 diabetes after a teplizumab injection
17 November 2022

Teplizumab: The world’s first type 1 diabetes disease-modifying drug approved in the US

Teplizumab, the world’s first type 1 diabetes disease-modifying drug, has been approved by the USA’s Food and Drug Administration (FDA).

Read more
A group of children wearing JDRF t-shirts
Prevention research
14 November 2022

New UK-first trial to screen children for type 1 diabetes opens for recruitment

A trial screening programme for type 1 diabetes that could transform the way the condition is identified and managed in its earliest stages, opens for recruitment today.

Read more
Theresa May MP, presenter Adam Smith, and JDRF CEO Karen Addington at JDRF's gala ball
Events Fundraising
11 November 2022

Gala Ball raises £125k for type 1 diabetes

JDRF’s first in-person annual Gala Ball since 2019 has raised £125,000 for type 1 diabetes research.

Read more
A woman using a Libre flash sensor and Novo Nordisk smart insulin pen
Treatments Type 1 technology
10 November 2022

FreeStyle Libre system now compatible with smart insulin pens

Abbott’s FreeStyle Libre systems and Novo Nordisk’s smart insulin pens can now link up virtually to help people with type 1 manage their diabetes more easily.

Read more
Terence Lovell, JDRF UK's fundraising and engagement director
Fundraising JDRF
9 November 2022

JDRF UK appoints Terence Lovell as Fundraising and Engagement Director

We are delighted to welcome Terence Lovell as Director of Fundraising and Engagement. Terence has worked in the not-for-profit sector for over 20 years.

Connect with us on social